Testosterone suppresses hepatic inflammation by the downregulation of IL-17, CXCL-9, and CXCL-10 in a mouse model of experimental acute cholangitis

Journal of Immunology

Volumn 194, Issue 6, 2015, Pages 2522-2530

  Schwinge, Dorothee ^a   Carambia, Antonella ^a   Quaas, Alexander ^a   Krech, Till ^a   Wegscheid, Claudia ^a   Tiegs, Gisa ^a   Prinz, Immo ^b   Lohse, Ansgar W ^a   Herkel, Johannes ^a   Schramm, Christoph ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CXCL9 CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 17; OVALBUMIN; TESTOSTERONE; ANDROGEN; CXCL10 PROTEIN, MOUSE; CXCL9 PROTEIN, MOUSE; OVA-8; PEPTIDE FRAGMENT;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE HEPATITIS; CASTRATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHOLANGITIS; CONTROLLED STUDY; DOWN REGULATION; EXPERIMENTAL ACUTE CHOLANGITIS; FEMALE; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; TESTOSTERONE BLOOD LEVEL; ACUTE DISEASE; ANIMAL; BLOOD; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; FLOW CYTOMETRY; GENETICS; HEPATITIS; IMMUNOLOGY; KNOCKOUT MOUSE; LIVER; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; TRANSPLANTATION;

ACUTE DISEASE; ADOPTIVE TRANSFER; ANDROGENS; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CXCL10; CHEMOKINE CXCL9; CHOLANGITIS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; HEPATITIS; INTERLEUKIN-17; LIVER; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; OVALBUMIN; PEPTIDE FRAGMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX FACTORS; TESTOSTERONE;

EID: 84924567287     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400076     Document Type: Article

References (40)

1. Gleicher, N., and D. H. Barad. 2007. Gender as risk factor for autoimmune diseases. J. Autoimmun. 28: 1-6.
2. Kaplan, M. M., and M. E. Gershwin. 2005. Primary biliary cirrhosis. N. Engl. J. Med. 353: 1261-1273.
3. Mieli-Vergani, G., and D. Vergani. 2011. Autoimmune hepatitis. Nature reviews. Gastroenterol. Hepatol. 8: 320-329.
4. Lleo, A., P. M. Battezzati, C. Selmi, M. E. Gershwin, and M. Podda. 2008. Is autoimmunity a matter of sex? Autoimmun. Rev. 7: 626-630.
5. Cohen, J. H., L. Danel, G. Cordier, S. Saez, and J. P. Revillard. 1983. Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells. J. Immunol. 131: 2767-2771.
6. McCarthy, M. 2000. The "gender gap" in autoimmune disease. Lancet 356: 1088.
7. Beagley, K. W., and C. M. Gockel. 2003. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol. Med. Microbiol. 38: 13-22.
8. Heneghan, M. A., S. M. Norris, J. G. O'Grady, P. M. Harrison, and I. G. McFarlane. 2001. Management and outcome of pregnancy in autoimmune hepatitis. Gut 48: 97-102.
9. Schramm, C., J. Herkel, U. Beuers, S. Kanzler, P. R. Galle, and A. W. Lohse. 2006. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am. J. Gastroenterol. 101: 556-560.
10. Wellge, B. E., M. Sterneck, A. Teufel, C. Rust, A. Franke, S. Schreiber, T. Berg, R. Günther, W. Kreisel, C. Zu Eulenburg, et al. 2011. Pregnancy in primary sclerosing cholangitis. Gut 60: 1117-1121.
11. Bengtsson, A. K., E. J. Ryan, D. Giordano, D. M. Magaletti, and E. A. Clark. 2004. 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. Blood 104: 1404-1410.
12. Gold, S. M., and R. R. Voskuhl. 2009. Estrogen and testosterone therapies in multiple sclerosis. Prog. Brain Res. 175: 239-251.
13. Chuang, Y. H., W. M. Ridgway, Y. Ueno, and M. E. Gershwin. 2008. Animal models of primary biliary cirrhosis. Clin. Liver Dis. 12: 333-347, ix (ix.).
14. McGargill, M. A., D. Mayerova, H. E. Stefanski, B. Koehn, E. A. Parke, S. C. Jameson, A. Panoskaltsis-Mortari, and K. A. Hogquist. 2002. A spontaneous CD8 T cell-dependent autoimmune disease to an antigen expressed under the human keratin 14 promoter. J. Immunol. 169: 2141-2147.
15. Stefanski, H. E., D. Mayerova, S. C. Jameson, and K. A. Hogquist. 2001. A low affinity TCR ligand restores positive selection of CD8+ T cells in vivo. J. Immunol. 166: 6602-6607.
16. Haas, J. D., S. Ravens, S. Düber, I. Sandrock, L. Oberdörfer, E. Kashani, V. Chennupati, L. Föhse, R. Naumann, S. Weiss, et al. 2012. Development of interleukin-17-producing gd T cells is restricted to a functional embryonic wave. Immunity 37: 48-59.
17. Dunn, S. E., S. S. Ousman, R. A. Sobel, L. Zuniga, S. E. Baranzini, S. Youssef, A. Crowell, J. Loh, J. Oksenberg, and L. Steinman. 2007. Peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity. J. Exp. Med. 204: 321-330.
18. Harrington, L. E., R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy, K. M. Murphy, and C. T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
19. Ishak, K., A. Baptista, L. Bianchi, F. Callea, J. De Groote, F. Gudat, H. Denk, V. Desmet, G. Korb, R. N. MacSween, et al. 1995. Histological grading and staging of chronic hepatitis. J. Hepatol. 22: 696-699.
20. Hohenester, S., U. Beuers, J. F. Medina, and R. P. Elferink. 2013. Antimitochondrial antibodies may be insufficiently specific to define primary biliary cirrhosis-like disease in mouse models. Hepatology 58: 828-830.
21. Leung, P. S., G. X. Yang, A. Dhirapong, K. Tsuneyama, W. M. Ridgway, and M. E. Gershwin. 2012. Animal models of primary biliary cirrhosis: materials and methods. Methods Mol. Biol. 900: 291-316.
22. Lapierre, P., K. Béland, C. Martin, F. Alvarez, Jr., and F. Alvarez. 2010. Forkhead box p3+ regulatory T cell underlies male resistance to experimental type 2 autoimmune hepatitis. Hepatology 51: 1789-1798.
23. Hammerich, L., F. Heymann, and F. Tacke. 2011. Role of IL-17 and Th17 cells in liver diseases. Clin. Dev. Immunol. 2011: 345803.
24. Lan, R. Y., T. L. Salunga, K. Tsuneyama, Z. X. Lian, G. X. Yang, W. Hsu, Y. Moritoki, A. A. Ansari, C. Kemper, J. Price, et al. 2009. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J. Autoimmun. 32: 43-51.
25. Rong, G., Y. Zhou, Y. Xiong, L. Zhou, H. Geng, T. Jiang, Y. Zhu, H. Lu, S. Zhang, P. Wang, et al. 2009. Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. Clin. Exp. Immunol. 156: 217-225.
26. Katt, J., D. Schwinge, T. Schoknecht, A. Quaas, I. Sobottka, E. Burandt, C. Becker, M. F. Neurath, A. W. Lohse, J. Herkel, and C. Schramm. 2013. Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis. Hepatology 58: 1084-1093.
27. Oo, Y. H., S. Shetty, and D. H. Adams. 2010. The role of chemokines in the recruitment of lymphocytes to the liver. Dig. Dis. 28: 31-44.
28. Rot, A., and U. H. von Andrian. 2004. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22: 891-928.
29. Cox, M. A., C. H. Jenh, W. Gonsiorek, J. Fine, S. K. Narula, P. J. Zavodny, and R. W. Hipkin. 2001. Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states. Mol. Pharmacol. 59: 707-715.
30. Curbishley, S. M., B. Eksteen, R. P. Gladue, P. Lalor, and D. H. Adams. 2005. CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. Am. J. Pathol. 167: 887-899.
31. Oo, Y. H., V. Banz, D. Kavanagh, E. Liaskou, D. R. Withers, E. Humphreys, G. M. Reynolds, L. Lee-Turner, N. Kalia, S. G. Hubscher, et al. 2012. CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver. J. Hepatol. 57: 1044-1051.
32. Lapierre, P., K. Béland, R. Yang, and F. Alvarez. 2013. Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance. Hepatology 57: 217-227.
33. Rowan, A. G., J. M. Fletcher, E. J. Ryan, B. Moran, J. E. Hegarty, C. O'Farrelly, and K. H. Mills. 2008. Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta. J. Immunol. 181: 4485-4494.
34. Quintero, O. L., M. J. Amador-Patarroyo, G. Montoya-Ortiz, A. Rojas-Villarraga, and J.M. Anaya. 2012. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J. Autoimmun. 38: J109-J119.
35. Bebo, B. F., Jr., E. Zelinka-Vincent, G. Adamus, D. Amundson, A. A. Vandenbark, and H. Offner. 1998. Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 84: 122-130.
36. Matejuk, A., K. Adlard, A. Zamora, M. Silverman, A. A. Vandenbark, and H. Offner. 2001. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis. J. Neurosci. Res. 65: 529-542.
37. Voskuhl, R. R., and K. Palaszynski. 2001. Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 7: 258-270.
38. Wei, T., and S. L. Lightman. 1997. The neuroendocrine axis in patients with multiple sclerosis. Brain 120: 1067-1076.
39. Markle, J. G., D. N. Frank, S. Mortin-Toth, C. E. Robertson, L. M. Feazel, U. Rolle-Kampczyk, M. von Bergen, K. D. McCoy, A. J. Macpherson, and J. S. Danska. 2013. Sex differences in the gut microbiome drive hormonedependent regulation of autoimmunity. Science 339: 1084-1088.
40. Liva, S. M., and R. R. Voskuhl. 2001. Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J. Immunol. 167: 2060-2067.